Table 2.
Gene* | Gene full name | Cardiac‐related diseases ** | Region | |
---|---|---|---|---|
ACADVL * | Acyl‐CoA Dehydrogenase, Very Long Chain | Hypertrophic cardiomyopathy; cardiac arrest; cardiomyopathies; sudden cardiac death; | Vessel | |
ALDH1B1 | Aldehyde Dehydrogenase 1 Family Member B1 | Coronary heart disease; coronary artery disease | Vessel | |
BCKDHB | Branched Chain Keto Acid Dehydrogenase E1 Subunit Beta | Multiple myeloma | Vessel | |
CS | Citrate Synthase | Cerebrovascular accident; angiomatosis, bacillary; cataract and cardiomyopathy; heart failure; cardiomyopathies | Vessel | |
DLAT | Dihydrolipoamide S‐acetyltransferase | Myocardial Ischemia | Vessel | |
ENO1 | Enolase 1 | Left ventricular hypertrophy; bacterial endocarditis; myocardial infarction; Behcet syndrome; acute coronary syndrome *** | Vessel | |
FN1 | Fibronectin 1 | Myocardial infarction; left ventricular hypertrophy; increase in blood pressure; aortic valve insufficiency; hypertensive disease | Vessel | |
IDH1 | Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic | Venous thrombosis; vascular neoplasms; hemangioma; hemangiomatosis; visceral angiomatosis | Vessel | |
ITGB1 | Integrin Subunit Beta 1 | Multiple myeloma; myocardial infarction; cardiomyopathy, dilated; heart failure; cardiomyopathies | Vessel | |
NDUFAB1 | NADH: Ubiquinone Oxidoreductase Subunit AB1 | Hypertensive disease; coronary artery disease | Vessel | |
NDUFS7 | NADH:Ubiquinone Oxidoreductase Core Subunit S7 | Cardiomyopathies | Vessel | |
NDUFV1 | NADH:Ubiquinone Oxidoreductase Core Subunit V1 | Hypertrophic cardiomyopathy | Vessel | |
PPP2R1A | Protein Phosphatase 2 Scaffold Subunit Alpha | Heart failure; congestive heart failure | Vessel | |
RPL11 | Ribosomal Protein L11 | Conduction disorder of the heart; electrocardiogram abnormal; electrocardiogram change; EKG abnormalities; cardiac conduction abnormalities | Vessel | |
SDHA | Succinate Dehydrogenase Complex Flavoprotein Subunit A | Hypertrophic cardiomyopathy; left ventricular noncompaction; gastrointestinal hemorrhage; cardiomyopathy, dilated, 1GG; cardiomyopathy, dilated | Vessel | |
TUBA1A | Tubulin Alpha 1A | Myocardial ischemia | Vessel | |
TXNRD2 | Thioredoxin Reductase 2 | Cardiomyopathy, dilated; myocardial infarction; cardiomyopathy, familial idiopathic; diabetic retinopathy; cerebrovascular accident | Vessel | |
ACAA1 | Acetyl‐CoA Acyltransferase 1 | Carotid atherosclerosis | Valves | |
ACAD9 | Acyl‐CoA Dehydrogenase Family Member 9 | Cardiomyopathy, dilated; hypertrophic cardiomyopathy; heart failure; congestive heart failure; cerebrovascular accident | Valves | |
ALDH9A1 | Aldehyde Dehydrogenase 9 Family Member A1 | Hypertensive disease | Valves | |
C1S | Complement C1s | Hereditary angioedema types I and II | Valves | |
CAPZB | Capping Actin Protein of Muscle Z‐line Beta Subunit | Acute coronary syndrome | Valves | |
CCT7 | Chaperonin Containing TCP1 Subunit 7 | Myocardial infarction | Valves | |
COPS5 | COP9 Signalosome Subunit 5 | Arteriosclerosis; atherosclerosis | Valves | |
DENR | Density Regulated RE‐1initiation and Release Factor | Heart failure; congestive heart failure; brain infarction; idiopathic pulmonary arterial hypertension | Valves | |
EIF2S2 | Eukaryotic Translation Initiation Factor 2 Subunit Beta | Multiple myeloma | Valves | |
EIF3E | Eukaryotic Translation Initiation Factor 3 Subunit E | Brain ischemia; intermittent claudication | Valves | |
FLNA | Filamin A | Heart valve disease; mitral valve prolapse syndrome; aortic valve insufficiency; heart failure; congestive heart failure | Valves | |
TPM3 | Tropomyosin 3 | Conduction disorder of the heart; electrocardiogram abnormal; electrocardiogram change; EKG abnormalities; cardiac conduction abnormalities | Valves | |
FXN | Frataxin | Cardiomyopathies; hypertrophic cardiomyopathy; heart failure; congestive heart failure; echocardiogram abnormal | Valves | |
HADHB | Hydroxyacyl‐CoA Dehydrogenasebeta Subunit | Cardiomyopathy, dilated; heart diseases; heart failure; congestive heart failure; cardiomyopathy, hypertrophic, familial | Valves | |
HSP90B1 | Heat Shock Protein 90 Beta Family Member 1 | Multiple myeloma; cerebrovascular disorders; atrial fibrillation; chronic atrial fibrillation | Valves | |
KIF5B | Kinesin Family Member 5B | Henoch‐Schoenlein purpura | Valves | |
LONP1 | Lon Peptidase 1, Mitochondrial | Endocardial cushion defects; atrial septal defects; ventricular septal defects; atrioventricular canal defect; heart failure | Valves | |
MYH11 | Myosin Heavy Chain 11 | Heart failure; congestive heart failure | Valves | |
NDUFS3 | NADH:Ubiquinone Oxidoreductase Core Subunit S3 | Cardiomyopathy, familial Idiopathic hypertrophic, 3 (disorder); cardiomyopathy, dilated, 1y; hypertrophic cardiomyopathy; cardiomyopathy, dilated; cardiomyopathy, hypertrophic, familial | Valves | |
PFKL | Phosphofructokinase, Liver Type | Cardiomyopathy, dilated; hypertrophic cardiomyopathy | Valves | |
PSMC5 | Proteasome 26S Subunit, ATPase 5 | Patent ductus arteriosus; hypertensive disease; aortic valve insufficiency; left‐sided heart failure; coronary artery disease | Valves | |
RPL11 | Ribosomal Protein L11 | Hypertrophic cardiomyopathy | Valves | |
SPTBN1 | Spectrin Beta, Non‐erythrocytic 1 | Ventricular septal defects; tetralogy of fallot | Valves | |
TPM1 | Tropomyosin 1 (alpha) | Arteriosclerosis; atherosclerosis | Valves | |
TPM3 | Tropomyosin 3 | Conduction disorder of the heart; electrocardiogram abnormal; electrocardiogram change; EKG abnormalities; cardiac conduction abnormalities | Valves | |
ACADVL | Acyl‐CoA Dehydrogenase, Very Long Chain | Hypertrophic cardiomyopathy; cardiac arrest; cardiomyopathies; sudden cardiac death | Cavities | |
ACSS1 | Acyl‐CoA Synthetase Short‐chain Family Member 1 | Cerebrovascular accident; subarachnoid hemorrhage; intracranial hemorrhages; cerebral hemorrhage | Cavities | |
AK1 | Adenylate Kinase 1 | Myocardial ischemia; myocardial infarction; infarction, middle cerebral artery | Cavities | |
ALDOA | Aldolase, FructosE‐1bisphosphate A | Myocardial ischemia | Cavities | |
CMPK1 | Cytidine/Uridine Monophosphate Kinase 1 | Kartagener syndrome | Cavities | |
DLD | Dihydrolipoamide Dehydrogenase | Hypertrophic cardiomyopathy; hypertensive disease; atrial fibrillation; atrial premature complexes | Cavities | |
EIF4E | Eukaryotic Translation Initiation Factor 4E | Multiple myeloma; myocardial ischemia; dementia, vascular | Cavities | |
EIF4H | Eukaryotic Translation Initiation Factor 4H | Williams syndrome; hypertensive disease; coronary artery disease | Cavities | |
GAPDH | GlyceraldehydE‐13‐phosphate Dehydrogenase | Bacterial endocarditis; ischemic cardiomyopathy; multiple myeloma; cardiomyopathy, familial idiopathic; acute coronary syndrome | Cavities | |
HADHA | Hydroxyacyl‐CoA Dehydrogenase, Alpha Subunit | Congestive heart failure; myocardial ischemia; cardiomyopathy, hypertrophic, familial; cardiomyopathy, dilated; cardiomyopathies | Cavities | |
HK1 | Hexokinase 1 | Myocardial ischemia; pulmonary hypertension | Cavities | |
HRG | Histidine Rich Glycoprotein | Thrombosis; myocardial infarction | Cavities | |
IDH1 | Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic | Venous thrombosis; vascular neoplasms; hemangioma; hemangiomatosis; visceral angiomatosis | Cavities | |
PDK2 | Pyruvate Dehydrogenase Kinase 2 | Cardiomyopathies | Cavities | |
PSMB1 | Proteasome Subunit Beta 1 | Acute coronary syndrome | Cavities | |
RPL28 | Ribosomal Protein L28 | Infarction, middle cerebral artery | Cavities | |
RPS2 | Ribosomal Protein S2 | Turner syndrome; Gonadal Dysgenesis, 45,X | Cavities | |
RPS9 | Ribosomal Protein S9 | Takayasu arteritis | Cavities | |
TSFM | Ts Translation Elongation Factor, Mitochondrial | Cardiomyopathies; patent ductus arteriosus; foramen ovale, patent; cardiomyopathy, concentric hypertrophic | Cavities | |
TXNRD2 | Thioredoxin Reductase 2 | Cardiomyopathy, dilated; myocardial infarction; cardiomyopathy, familial idiopathic; diabetic retinopathy; cerebrovascular accident | Cavities | |
VAMP3 | Vesicle Associated Membrane Protein 3 | Coronary artery disease | Cavities |
The region‐specific genes of monkey heart enriched in protein–protein interactions above were imported to a gene‐disease association analysis.
These genes associated with heart diseases were listed and involved in one or more cardiac‐related illnesses.
We only displayed the five major heart‐related disorders for one gene when exceeding this limit.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.